Regarding chemokine receptors, ZDHHC19 displayed a generally positive correlation with chemokine receptors in most cancers, except for adrenocortical carcinoma, endometrial carcinoma, uterine sarcoma, and uveal melanoma, where it was negatively correlated with chemokine receptors (Figure 8d,e). Here, ZDHHC19 is linked to cancer.